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Abstract 
Prolactin hormone is a polypeptide hormone of pituitary origin, whose production is controlled by dopamine. 
Hyperprolactinemia is characterized by increased production of     prolactin hormone levels often leading to 
reproductive dysfunction. The aim of this study is to investigate if there is any genetic variation or changes in 
nucleotide sequences of Exon 1 of prolactin receptor gene behind infertile cases of Iraqi women patients 
suffering from hyperprolactinemia. For this study 15 samples from infertile hyperprolactinemic women were 
taken and genomic DNA was extracted, specific primers was designed to amplify specific portion of prolactin 
receptor gene (Exon 1) using PCR technique . The PCR products of both healthy and hyperprolactinemic 
infertile women were subjected for DNA sequencing by machine AB137 30KL, Applied Biosystem, Macrogene 
company, USA. Polymorphic variants were identified , data obtained which is heterozygous SNP and SNPs was 
found between individuals. The DNA sequencing results of receptor from patients was found to be compatible 
99% and score 481 with the wild type sequence of gene bank.  And the differences may be attributed to one 
transition mutation (G/A) at position 61 of exon 1. Its substitution mutation that leads to changes amino acid 
from Arginen  to Lysin. 
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1. Introduction 
Prolactin is the hormone that is secreted predominantly by lactotrophs in the anterior pituitary gland (1). 
Hyperprolactinemia is a condition of elevated serum prolactin,  is characterized by increased production of 
prolactin, often leading to reproductive dysfunction and galactorrhoea (2). In humans  the prolactin receptor 
gene is member of the large class-1-cytokine receptor super family(4). Only a single isoform of the prolactin 
receptor has been identified in humans (5). It’s located on chromosome 5 and is approximately 180 kb in length 
and is originally having 10 exons of which (3-10) coding exon.(6),(7). 
The effect of prolactin are mediated by interaction with specific cells surface high affinity prolactin receptor 
(PRLR)(3). The binding of prolactin is mediated with its receptor (PRLR), the binding of prolactin activates the 
pre-dimerized prolactin  receptor and result in activation of prolactin receptor-associated signaling cascades such 
as Jak2/Stat5 result in transactivation of prolactin-responsive genes(8). 
The aim of this study is to investigate if there is  variation in PRLR gene of hyperprolactinemic infertile woman 
by taking a closer look of DNA sequencing of them, so a portion of the PRLR gene was amplified by PCR  using 
specific primers for Exon1 of PRLR gene also amplified for samples of hyperprolactinmic infertile patients and 
healthy fertile women as control. 
 
1.1 Materials and methods 
Sample were collected after diagnose as infertile hyperprolactemic patients by consultants, its collected from 
(15), infertile women sueffering from hyperprolactinemia their ages ranged between(20-50) years. 
A volume of 5 ml of peripheral blood was collected by vein puncture tubes. Genomic DNA was extracted   from 
whole blood by using DNA extraction kit Promega. The primers that have been selected for this study to amplify 
portion of prolactin receptor gene was designed, and the details were illustrated in (table 1). The preparation of 
PCR reaction was carried out in 25ml by using green master mix and the amplification condition were illustrated 
in table(2), for all  primers. Then after amplification, 15 of PCR product (10 as abnormal, 5 as control) were 
send for DNA  sequencing, the sequence reaction were performed .  
1.1.1. Results and discussion 
  In this study  the extraction was accurate for all samples by showing clear bands for all samples of 
hyperprolactinemic patients and for healthy control samples, Three hundred and seven bp were amplified by 
using primer 1, three hundred and six bp were amplified by PCR using primer 2,  three hundred eighty two bp 
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were obtained by using primer 3 and four hundred thirty six bp was amplified using primer 4 , and they are 
indicated by agarose gel electrophoresis for all samples as shown in  figure 1(a, b, c)  and 2. 
 
1.1.2. Detection of mutation in PRLR gene. 
The prolactin gene receptor was sequenced by sending PCR product of   primer 2 (306 bp) which amplify the 
region from 5013 to 5318 and  of primer 4 (436 bp),  which amplify the region from 5020 to 5455. Homology 
searches were conducted between the sequences of standard gene blast program which is available at the national 
center for biotechnology information (NCBI), and Mega6 program. Results of sequencing of the coding regions 
of the amplified product (exon 1) for these samples were done for seeking of any mutations within these 
sequencing related to hyperprolactinemic patients. It's clear that the product of primer 2 have one  mutation in 
sample 5  site (61),which is obvious in table (3) shown type of mutation and predicted effect in which it changes 
the  codon from AGA to AAA, that change the a.a from Arg to Lys. The peaks is obvious in figure (3), while the 
blast of it in NCBI is clear in figure (4). In this study there is an association between the PRLR  gene mutation 
(that happened in sample 5 of hyperprolactemic patient), and hyperprolactinemia , this result agrees with those of  
Newey et al., ( 2013) where shown  that there were a heterozygous mutation in the prolactin receptor gene 
resulting in an amino acid change but histidine to arginine at codon 188, and this substitution disrupted the high 
affininty ligand-binding interface of the prolactin receptor resulting in a loss of downstream signaling by Janus 
Kinase2 (JAK2) and Signal transducer and activator of 
 
transcription 5(STAT5), this resulted  in a loss of function which lead to hyperprlactinemia(9). This result was 
coincidence with the study of Vaclavicek et al.,( 2006)(10), when there are first screened the promoter regions 
and one SNP in each exon 5 and exon 6 which were supposed to change a.a , but the SNPs did  not exist or they 
were too rare they were not considered. In this study, we choose the exon 1 as the PRLR gene region is not 
equally well characterized in the public database NCBI as PRL gene, also the exon 1 that exists in several variant 
forms and in non coding region(11). As a human PRLR is a single transmembrane spanning protein belonging to 
a superfamily of growth hormone/prolactin/cytokine receptors and alternative splicing result in different 
isoforms of PRLR (12) This isoforms of PRLR have different effect on intracellular signaling that may be 
stimulatory or inhibitory. These results suggested that the SNPs is located within non coding regions of PRLR 
genes based on location, the most likely mechanisms responsible for increased risk is through effect on 
transcriptional regulation (13). Also one other PRLR variant  causing a change from Isoleucine to Leucine at 
codon 146 in the extracellular domain of the mature protein and resulting in an increased basal JAK2-STAT5 
signaling invitro as Bogorad et al., 2008(14). 
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Notes 
Table 1. Sequences of primers used to amplify human prolactin gene receptor: 
No. Oligonucleotides Oligosequance Prod. 
Size 
(bp) 
GC% TM Ref. 
1 Forward primer 
 
Reverse primer 
TCTTCGCAGGATTCCAGCTC 
CGCGAACGGTCGGTAAAATC 
 
307 
55.00 
 
55.00 
53.83 
 
53.83 
 
NCBI 
2 Forward primer 
 
Reverse primer 
GCCCTAATCATGCAAAACCGA 
GAAAGCCCAGCCCAGAAAAC 
 
306 
47.62 
 
55.00 
52.40 
 
53.83 
 
NCBI 
3  Forward primer 
 
Reverse primer 
GGCAGGCTCTGGACGTTTT 
TCCTCAGTGTTCGCCTCCAT 
 
 
382 
57.00 
 
55.00 
 
53.25 
 
35.83 
 
 
NCBI 
4 Forward primer 
 
Reverse primer 
TCATGCAAAACCGATCTGGG 
GTTTTGCCAGGGAGCAAAGT 
 
436 
50.00 
 
50.00 
51.78 
 
51.78 
 
NCBI 
 
Table (2) 
Program of PCR used for amplification of prolactin receptor gene using primer 1: 
Thermal cycler protocol No. of cycle Temperature –time 
Initial Denaturation 1 cycle 94 oC for 5 minutes 
Denaturation  
35cycle 
94 oC for 1 min 
Annealing 61 oC for 1 min 
Extension 72 oC for 1 min 
Final Extension 1 cycle 72 o C for 10 mins. 
 
Program of PCR used for amplification of prolactin receptor gene using primer 2: 
Thermal cycler protocol No. of cycle Temperature –time 
Initial Denaturation 1 cycle 94 oC for 5 minutes 
Denaturation  
35cycle 
94 oC for 1 min 
Annealing 57 oC for 1 min 
Extension 72 oC for 1 min 
Final Extension 1 cycle 72 o C for 10 mins. 
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Program of PCR used for amplification of prolactin receptor gene using primer 3: 
Thermal cycler protocol No. of cycle Temperature –time 
Initial Denaturation 1 cycle 94 oC for 5 minutes 
Denaturation  
35cycle 
94 oC for 1 min 
Annealing 57 oC for 1 min 
Extension 72 oC for 1 min 
Final Extension 1 cycle 72 o C for 10 mins. 
 
Program of PCR used for amplification of prolactin receptor gene using primer 4: 
 
Thermal cycler protocol No. of cycle Temperature –time 
Initial Denaturation 1 cycle 94 oC for 5 minutes 
Denaturation  
35cycle 
94 oC for 1 min 
Annealing 57oC for 1 min 
Extension 72 oC for 1 min 
Final Extension 1 cycle 72 o C for 10 mins. 
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Figure (1; a, b and c): Gel electrophoresis of (a) PRLR 1, product size 307 bp.   (b) PRLR 2 product size 
306 bp.(c) PRLR3 product size 382 bp.Electrophoresis ( 1.5% agarose gel, at 80v/mAMP for 50min). Line 
A=100bp ladder, line (1-10), line (11) control negative. 
 
 
 
 
 
Figure (2): Gel electrophoresis of amplification of PRLR4  of hyperprolactinemic patients  product size 
436 bp. Electrophoresis was performed on 1.5% agarose gel and run with a 80v/mAMP  current for 
50min.Line A=100bp ladder, line (1-10) DNA isolated from blood samples of hyperprolactinemic patients, 
line (11) healthy and line (12) control negative. 
 
 
 
 
 
 
 
 
 
 
 
 Figure (3): Peaks of sample 5, that indicate the substitution mutation. 
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Figure (4): NCBI of hyperprlactemic patient (sample 5), of  PRLR gene. 
 
Table (3): Mutations of human PRLR gene of hyperprolactemic patients 
Type of 
mutation 
Site on 
nucleic 
acid  
Change in 
a.a 
Mutant 
type 
Wild type Site on 
gene 
No. of 
patient 
sample 
Substitution 61 Arg/Lys AAA AGA Exon 1 5 
 
 
